Bradley & Co Private Wealth Management’s AbbVie ABBV Stock Holding History

Bradley & Co Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32K	Hold	147	–	–	0.02%	104
2025 Q4	$33.6K	Sell	147 -50	-25%	-$11.4K	0.02%	101
2025 Q3	$45.6K	Buy	197 +20	+11%	+$4.07K	0.03%	83
2025 Q2	$32.9K	Hold	177	–	–	0.02%	86
2025 Q1	$37.1K	Hold	177	–	–	0.03%	80
2024 Q4	$31.5K	Buy	+177	New	+$32.5K	0.02%	87
2024 Q2	$30.4K	Hold	177	–	–	0.02%	83
2024 Q1	$32.2K	Hold	177	–	–	0.03%	82
2023 Q4	$27.4K	Hold	177	–	–	0.03%	82
2023 Q3	$26.4K	Hold	177	–	–	0.03%	83
2023 Q2	$23.8K	Hold	177	–	–	0.02%	88
2023 Q1	$28.2K	Hold	177	–	–	0.03%	81
2022 Q4	$28.6K	Hold	177	–	–	0.03%	80
2022 Q3	$24K	Hold	177	–	–	0.03%	91
2022 Q2	$27K	Buy	177 +79	+81%	+$12.1K	0.03%	101
2022 Q1	$16K	Hold	98	–	–	0.01%	119
2021 Q4	$13K	Hold	98	–	–	0.01%	126
2021 Q3	$10K	Hold	98	–	–	0.01%	138
2021 Q2	$11K	Hold	98	–	–	0.01%	137
2021 Q1	$10K	Buy	+98	New	+$10.5K	0.01%	139

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bradley & Co Private Wealth Management's ABBV Position: Q1 2026 in Review

Bradley & Co Private Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 147 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #104.

Bradley & Co Private Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 20 quarters since. The position peaked at $45.6K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bradley & Co Private Wealth Management held 147 shares of AbbVie worth $32K as of Q1 2026.
Bradley & Co Private Wealth Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.02% of Bradley & Co Private Wealth Management's portfolio in Q1 2026, its #104 holding.
Bradley & Co Private Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 20 quarters since.
Bradley & Co Private Wealth Management's AbbVie position peaked at $45.6K in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bradley & Co Private Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.